FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

72024007: Tetrahydrocannabinol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
119683016 Tetrahydrocannabinol en Synonym Active Entire term case insensitive SNOMED CT core module
812256017 Tetrahydrocannabinol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2647311018 delta-9-Tetrahydrocannabinol en Synonym Inactive Only initial character case insensitive SNOMED CT core module
46575101000001115 Delta-9-tetrahydrocannabinol en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetrahydrocannabinol Is a Marijuana derivative false Inferred relationship Existential restriction modifier
Tetrahydrocannabinol Is a Marijuana derivative false Inferred relationship Existential restriction modifier
Tetrahydrocannabinol Is a Cannabinoid true Inferred relationship Existential restriction modifier
Tetrahydrocannabinol Has disposition Cannabinoid receptor agonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Delta-9-tetrahydrocannabinol measurement Component False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Delta-9-tetrahydrocannabinol Is a True Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Has precise active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Has basis of strength substance False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Product containing cannabinol and tetrahydrocannabinol (medicinal product) Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Product containing cannabinol and tetrahydrocannabinol in oral dose form (medicinal product form) Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Product containing only cannabinol and tetrahydrocannabinol in oral dose form (medicinal product form) Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Product containing only cannabinol and tetrahydrocannabinol (medicinal product) Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Dronabinol Is a True Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Mass concentration of 11-nor-9-carboxy-tetrahydrocannabinol cannabis metabolite in urine (observable entity) Component True Tetrahydrocannabinol Inferred relationship Existential restriction modifier 1
Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 204 dose Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 204 dose 4 x 51 doses Has active ingredient False Tetrahydrocannabinol Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start